background: To test our hypothesis that eutopic secretory phase endometrium from women with endometriosis is similar to proliferative phase endometrium from fertile women without endometriosis, we explored the expression of regulators of cell fate across the menstrual cycle.
Introduction
Endometrium is a dynamic organ that undergoes well-characterized cyclical changes during the reproductive age-range. These changes are closely controlled by the ovarian hormones and disappear after the menopause. The monthly cycle of proliferation, differentiation, tissue breakdown and regeneration provides a unique and accessible opportunity for in vivo investigation of repetitive physiological injury and repair and cell kinetics. The importance of understanding endometrial cell kinetics is highlighted by the clinical condition of endometriosis. Endometriosis is defined as the presence of endometrial-like glands and stroma at ectopic sites beyond the uterine cavity and is a common cause of pelvic pain and may also increase the risk of developing some cancers (Matalliotakis et al., 2006 (Matalliotakis et al., , 2008 . The eutopic endometrial cells of women with endometriosis appear to have a proproliferative and pro-survival phenotype compared with women without endometriosis (Harada et al., 2007) . We have recently reported that endometriosis is associated with abnormal expression of telomerase and telomere lengthening of the eutopic secretory phase endometrium (Hapangama et al., 2008a) . These observations suggest that the endometriosis is associated with a state of sustained replication in eutopic endometrium and support a model for the pathogenesis of endometriosis under which sloughed endometrium has enhanced replicative capacity and an ability to persist in an adverse environment. This is compatible with the concept that endometriosis occurs when tissue that has been expelled into the pelvic cavity via retrograde menstruation has implanted ectopically (Sampson 1927) .
The concept of sustained replication implies that several cellular processes are well coordinated in the endometrium of women with endometriosis. Sustained replication will depend on close regulation of cell division, including DNA replication, and cell growth. In addition, sustained replication will increase the risk of DNA damage. Several markers of the replicative state can provide information about these processes.
Nucleolin is a multifunctional DNA-binding nucleolar phosphorprotein involved in gene transcription and chromatin re-modelling of exponentially growing eukaryotic cells (Grinstein and Wernet, 2007) . It is also involved in multiple steps in ribosomal RNA transcription, maturation and assembly (Mongelard and Bouvet, 2007) . Proliferating cell nuclear antigen (PCNA) is a cofactor of DNA polymerases that encircles DNA, coordinates cell proliferation by recruiting crucial players to the DNA replication fork and is essential for DNA mismatch repair (Moldovan et al., 2007 , Li 2008 . Expression of PCNA may localize the cellular damage tolerance mechanisms to where they are needed and therefore appears to contribute to an appropriate balance between cell survival and genome stability (Ulrich, 2007) . Both of these proteins can be reliably immunolocalized (Ioachin, 2005; Wu et al., 2006) , yet the expression of nucleolin in endometrium has not been described to date.
Various forms of DNA damage lead to the induction of a DNA damage response. One of the earliest events in a DNA damage response is the phosphorylation of Ser139 at the carboxy terminus of the histone protein H2AX leading to the formation of g-H2AX foci. g-H2AX foci mediate the recruitment of numerous DNA damage recognition and repair factors to the immediate vicinity of the DNA lesion, which promotes repair and prevents chromosomal breaks (Fillingham et al., 2006; Franco et al., 2006) . There are two major mechanisms to activate H2AX phosphorylation: (i) replication stress, i.e. stalled replication forks with concomitant formation of single-stranded DNA, which occurs in actively cycling cells and will most often induce a transient DNA damage response (Ward et al., 2004) and (ii) persistent DNA double-strand breaks (DSBs) or uncapped telomeres which are associated with long-term proliferation arrest and cellular senescence or, possibly, apoptosis (d'Adda di Fagagna et al., 2003; Shiloh, 2003; von Zglinicki et al., 2004) . Recent development of antibodies specific to g-H2AX foci and their employment in immunohistochemical studies has permitted the in situ detection of DNA damage and repair in tissues (Banáth and Olive, 2003) . We are not aware of any studies of g-H2AX expression in the endometrium.
In the present study, we have investigated the state of sustained replication suggested by our previous work. We hypothesized that replicative markers expressed in endometrium from healthy women during the proliferative phase would be present in endometrium from women with endometriosis during other phases of the menstrual cycle. In order to address this hypothesis, we examined endometrium obtained during the proliferative and secretory phases from women with, and without, endometriosis. Our aims were:
(i) to compare the immunohistochemical expression of nucleolin and PCNA between women with endometriosis and healthy, fertile controls; (ii) to compare the immunohistochemical expression of g-H2AX between women with endometriosis and healthy, fertile controls; and (iii) to compare expression of nucleolin, PCNA and g-H2AX with previously reported markers of cell fate, including telomere length (TL).
Materials and Methods
Ethical approval for this study was obtained from the Liverpool Adult Local Research Ethics Committee and informed written consent was obtained from all participants in the study prior to inclusion. Seventy-three premenopausal women aged 18 -45 years were recruited to this prospective, single-centre, observational, non-therapeutic, pilot study. The results of telomerase immunohistochemistry, telomerase activity assay and measurement of TL in endometrial and peripheral blood samples in this group during the secretory phase of the cycle (n ¼ 56) have been reported previously (Hapangama et al., 2008a ). In the current study, we used all 56 tissue sections from the same samples of endometrium in the secretory phase obtained from healthy, fertile women (n ¼ 27) and from women with endometriosis (n ¼ 29) as we presented in Hapangama et al. (2008a) . The current report also includes data obtained from samples of a further three mid secretory phase fertile control women and proliferative phase endometrium collected from women with (n ¼ 9) and without endometriosis (n ¼ 5) that were not included in Hapangama et al. (2008a) . All women included had regular menstrual cycle (26 -30 days), were not taking any hormonal treatments and were not using an intrauterine contraceptive device. Group 1 consisted of 38 women with surgically diagnosed active, peritoneal endometriosis at American Fertility Society Stages I -IV. Group 2 consisted of 35 fertile women who were recruited prior to laparoscopy while undergoing female sterilization and were found to have no detectable endometriosis and had no history of symptoms or prior diagnosis of the condition. A pipelle endometrial sampler (Prodimed, Neuilly-en-Thelle, France) was used to obtain a sample of endometrium and the stage of the cycle was estimated by histological dating according to recent modifications of Noyes criteria by two experienced pathologists (Murray et al., 2004) , patient reported date of last menstrual period and serum estradiol (E 2 ) and progesterone levels. Endometrial biopsies were taken during the proliferative phase (cycle days 5-12), window of implantation (WOI, cycle days 21 + 2) and in the late secretory phase (cycle days 26 + 2) of the cycle in both groups as shown in Table I . A blood sample was taken at the time of the endometrial biopsy for the assessment of serum E 2 and progesterone levels and peripheral blood TL. Endometrial samples were divided into two parts and one part was fixed for 24 h at 48C in 4% buffered formalin, rinsed and routinely waxembedded. The other part was immediately snap frozen with liquid nitrogen and was kept at 2708C for DNA/RNA studies.
Immunohistochemistry
Immunohistochemistry was performed by standard methods using horseradish-peroxidase-conjugated secondary antibodies and immunereactivity was detected using the chromagen, 3,3 0 -diaminobenzidine (DAB) for nucleolin, PCNA, telomerase and g-H2AX. The commercially obtained primary antibodies used were against human nucleolin (NCL, Novo Castra, Newcastle-upon-Tyne, UK), human PCNA (DAKO, UK), human telomerase (Abcam, Cambridge, UK) and g-H2AX (S139, rabbit polyclonal, Cell Signalling, UK) (Table II) .
Briefly, 5 m-thick sections of endometrial specimens were deparaffinized through a series of xylene baths, and the samples were re-hydrated through ascending grades of alcohol to Tris-buffered saline (TBS). To enhance epitope exposure, high-temperature antigen retrieval step was carried out by pressure cooking the slides at 988C with 0.01 M citrate buffer at pH 6 for 4 min. Endogenous peroxidise was quenched in 3% H 2 O 2 . After washing with TBS, the non-specific antibody binding was blocked with 10% normal goat serum. The sections were then incubated with the primary antibody in a humidifying chamber. After washing, the sections were incubated in the labelled polymer, and incubating with DAB developed brown or black positive staining according to the manufacturer's guidelines. The sections were lightly counterstained with Meyer's haematoxylin or methyl green, and mounted.
TL measurement by real-time PCR
Genomic DNA was extracted from endometrial cells and the TL was measured by quantitative real-time PCR as described previously (Hapangama et al., 2008a, b) . Measurements were performed in quadruplicate. Three DNA samples with known TLs were run as internal standards in each batch of samples. Mean TL is expressed in base pairs (bp). Replication without DNA damage in endometriosis Analysis of nucleolin, PCNA and telomerase immunostaining
All slides were coded, and scored by two independent observers prior to breaking the code. Distribution and intensity of brown positive immunostaining for nucleolin, PCNA and telomerase within the different cell types in the endometrium (glandular and luminal epithelium, and stroma) was measured using a standard semi-quantitative scoring system with demonstrated high correlation between objectively measured immunoreactivity (image analysis) and subjective semi-quantitative scoring of immunostaining patterns used in previous studies (Wang et al., 1998; Hapangama et al., 2002 Hapangama et al., , 2008a . This method employs a four-point semi-quantitative scoring system based on a global assessment of all slides relating to each participant. Positive staining was classified as negative/no staining ¼ 0, weak ¼ þ/2, strong ¼ þ and very strong ¼ þþ as described previously (Hapangama et al., 2002 (Hapangama et al., , 2008a .
Analysis of g-H2AX immunostaining
The presence or absence of a distinct black nuclear g-H2AX immune-staining pattern against the methyl green background was assessed as the percentage of g-H2AX antigen-positive cells by employing a computer-assisted image analysis system, which was adapted for this purpose. Digital images of 10 randomly selected high-power (Â400) fields were captured on Eclipse-net software (Nikon). Glands and stroma were analysed separately after removing the blood vessels from the images using the 'Lasso' tool on Adobe Photoshop CS2 software (Adobe, San Jose, USA). ImageJ freeware (NIH, USA) was then used to convert the image to 8-bit grey scale. The total number of glandular epithelial or stromal cells was determined using a manual threshold followed by application of the 'watershed' function, which generated a visual array in which each cell was black and the non-cellular material was white. Cells were then automatically counted with the 'analyse particles' function. Finally, a visual check was performed utilizing the 'colour merge' function in ImageJ. The numbers of g-H2AX immunopositive endometrial cells in each field were then counted using the manual pick tool in the ImageJ software and the percentage of g-H2AX-positive cells per field determined as a function of the total number of epithelial or stromal cells. This technique has been shown to have good inter-and intra-observer reliability (Drury et al., 2007) .
Statistical analysis
The Statistical Package for the Social Sciences version 14.0 for Windows statistical programme was used for all calculations. Semi-quantitative scores from different groups were compared by non-parametric tests as appropriate. Two-way analysis of variance (ANOVA) models, including interactions, were used to explore the joint effects of endometriosis and the timing of the biopsy on g-H2AX and TL. For outcomes where group or phase of the menstrual cycle was the only significant factor, results were checked using the Mann-Whitney or Kruskal -Wallis test as appropriate. Where the ANOVA results indicated group and phase of the menstrual cycle were both important (including an interaction), a sensitivity analysis was carried out. Ordinal regression or logistic regression, using robust estimation of variance, was carried out in Intercooled Stata 9. A value of P , 0.05 was considered significant.
Results

Demographics
Patient characteristics, TLs, results of telomerase immunohistochemistry and the telomere repeat amplification protocol assay plus E 2 and progesterone levels of 56 women in the secretory phase have been described previously (Hapangama et al., 2008a) . Women in the fertile control group were more likely to be multi-parous (P ¼ 0.0001), older (P ¼ 0.02) and shorter (P ¼ 0.04) than the endometriosis group. Age, BMI, height and weight in each group are illustrated in Table III . Circulating E 2 and progesterone values did not show a significant difference between the two groups at each of the three time points examined in the ovarian cycle (P . 0.05).
Immunohistochemistry
Nucleolin
Paraffin sections of colonic adenocarcinoma (Fig. 1ia) LSP, late secretory phase. Women in the FC group were more likely to be multi-parous (P ¼ 0.0001), older (P ¼ 0.02) and shorter (P ¼ 0.04) than the women in the Endo group but weight was not significantly different (P . 0.05). Circulating estradiol and progesterone values did not show a significant difference between the two groups at each of the three time points examined in the ovarian cycle (P . 0.05). All differences were tested by Mann -Whitney U-test. (WOI); (e) Endo WOI; (f) FC late-secretory endometrium (LS); (g) Endo LS. Scale bar ¼ 500 mm (ia, id and ivb) applicable to all panels. External positive controls for nucleolin ¼ human adeno-carcinoma of the colon (ia), PCNA ¼ human tonsil (iia), g-H2AX ¼ tissue with high lifetime exposure to UV radiation (human skin from neck, iiia) and for telomerase ¼ human tonsilar cortex (iva). In proliferative phase, both groups showed positive staining for all the markers studied (i -iv, b and c).
Note the paradoxical decrease of the proliferative markers and an increased g-H2AX immune-reactivity in the FC WOI and LS (i -iv, d and f).
In Endo samples, the immune-staining for the proliferative markers were increased with weak or no g-H2AX immune-reactivity in the WOI or LS (i -iv, e and g).
Replication without DNA damage in endometriosis and specific brown nuclear nucleolin staining was seen in all. Mouse immunoglobulin G (DAKO, USA) was used as the negative control. Healthy fertile women showed strong nucleolin immune-reactivity in proliferative phase endometrium which declined to either weak or absent staining in all tissue compartments studied in the mid/late secretory phase (Figs 1ib, id and if, and 2a and b). The secretory phase endometrial tissue from women suffering with endometriosis showed increased nucleolin immunoreactivity both in the mid secretory and late secretory phase and this difference between women with and without disease was significant (P , 0.0001 in both stromal and glandular compartments; Figs 1ic, ie and ig, and 2a and b). FC PROL, n ¼ 5; Endo PROL, n ¼ 9; FC WOI, n ¼ 18; Endo WOI, n ¼ 17; FC LS, n ¼ 12; Endo LS, n ¼ 12. Error bar ¼ SEM. P-values (from analysis of variance) are shown under each chart for the main effects of the timing of the biopsy in the cycle (phase) and endometriosis (study group), and the interaction between the phase and endometriosis on the mean semi-quantitative scores for markers of cell fate.
Proliferating cell nuclear antigen
The positive nuclear PCNA staining seen in all cellular compartments during the proliferative phase endometrium declined to weak or absent staining in the secretory phase in fertile healthy women. Women with endometriosis, however, showed a significant persistence in the brown nuclear positive PCNA staining throughout the cycle, including the secretory phase (glandular epithelium P , 0.001, stroma P , 0.01). The difference in both glandular and stromal staining patterns showed a significant interaction at the WOI and at the late secretory phase (P ¼ 0.002) (Figs 1iia-h, and 2a and b).
Telomerase
The proliferative phase endometrial samples from both groups showed telomerase immune-reactivity in all tissue compartments studied and there were no differences between the two groups (P ¼ 0.06 for the glands, P ¼ 0.14 for the stroma). Secretory phase immune-staining of the women from both groups has been previously reported (Hapangama et al., 2008a) . Briefly, the stromal and glandular telomerase expression pattern showed a decrease from proliferative phase to secretory phase in fertile women, whereas the opposite was true for women with endometriosis (Figs 1iva -h, and 2a and b).
g-H2AX immunostaining
Figures 1iiia -h, and 2a and b show the effect of menstrual cycle on g-H2AX staining in women with endometriosis and healthy controls. All women showed positive stromal and glandular nuclear g-H2AX immune-staining in the proliferative phase. In healthy women, stromal g-H2AX staining was present in the proliferative phase Replication without DNA damage in endometriosis (7.9% of cells) but more frequent in the secretory phase, with the highest levels in the late secretory phase (15.6%) (P , 0.05). The reverse was true for the glands, where glandular g-H2AX staining had the lowest levels in the late secretory phase (6.7%) (P ¼ 0.02).
In women with endometriosis, g-H2AX staining was positive in stromal and glandular compartments in the proliferative phase, similar to healthy controls (P ¼ 0.28 for stroma, P ¼ 0.21 for glands). However, in the secretory phase, g-H2AX staining in women with endometriosis differed from that in healthy women: low or absent g-H2AX staining was seen in both stromal (P , 0.0001) and glandular compartments (P , 0.05) of women with endometriosis compared with healthy women in the secretory phase. Two-way ANOVA showed that the apparent interaction between the phase of the menstrual cycle and the study group was significant for stroma (P ¼ 0.009). That is, the effect of menstrual cycle phase on stromal expression of g-H2AX differed between women with endometriosis and healthy controls. In the glands, g-H2AX expression was significantly lower in women with endometriosis at all phases of the cycle (P ¼ 0.002), and in both groups, the menstrual cycle phase had a similar effect on glandular g-H2AX expression (P , 0.0001). Although limited by small sample sizes, the results from the ordinal and logistic regression were consistent with those from ANOVA, both in terms of statistical significance and the nature of the effects.
Mean TL
Mean endometrial TL positively correlated with the glandular and stromal expression of nucleolin (glandular r ¼ 0.37, P ¼ 0.002; stromal r ¼ 0.4, P ¼ 0.001), and telomerase immunoreactivity (glandular r ¼ 0.33, P ¼ 0.009; stromal r ¼ 0.4, P ¼ 0.001) (Fig. 3) . Further positive correlation was also seen between the mean endometrial TL and glandular immunostaining for PCNA (r ¼ 0.35, P ¼ 0.004). On the other hand, a significant negative correlation was seen between stromal g-H2AX expression and mean endometrial TL (r ¼ 20.28, P ¼ 0.04).
Discussion
This study is the first to examine the expression of nucleolin and g-H2AX in human endometrium at a cellular level and we have immunolocalized nucleolin and g-H2AX in endometrium from healthy fertile women. Expression of nucleolin and PCNA was comparable with the expression of other markers of proliferation such as telomerase. As expected, g-H2AX expression was congruent with markers of proliferation in the proliferative phase. However, in endometrial stroma, g-H2AX expression was greater in secretory phase than in the proliferative phase, unlike expression of the markers of proliferation. We also examined the expression of nucleolin, PCNA and g-H2AX in endometrium from women with endometriosis. In these women, nucleolin expression was congruent with markers of proliferation. However, among women with endometriosis, g-H2AX expression was lower in the secretory phase, irrespective of cell type. This suggests that the capacity for enhanced replication in eutopic endometrium during the secretory phase among women with endometriosis does not represent a simple extension of the proliferative phase.
Significance of proliferative markers
The localization of nucleolin in endometrium has not been described previously. The monoclonal mouse anti-human antibody we used has been shown to recognize nucleolin by the use of mass spectrometry, two-dimensional gel analysis and immunofluorescent experiments (Wu et al., 2006) . The only published report concerning uterine nucleolin expression was in rabbit and utilized western blot analysis that neglects the importance of cellular level nucleolin expression in the endometrial tissue (Yokoyama et al., 1998) . Their results suggested that nucleolin expression is dependent on ovarian steroids and is associated with the proliferative potential of the endometrial cells (Yokoyama et al., 1998) . The expression pattern of PCNA and telomerase in the fertile control group (i.e. expressed in the proliferative phase and declining in the secretory phase) is consistent with the previous reports using mRNA, enzyme activity or culture/animal models (Kyo et al., 1996; Williams et al., 2001; Niklaus et al., 2007) .
The functions of nucleolin include fundamental aspects of global transcriptional regulation, cell proliferation and growth (Mongelard et al., 2007) . Proliferating cells require an optimal level of protein synthesis for proliferation, cell metabolism and repair. Therefore, nucleolin expression may control endometrial cell proliferation and growth by direct involvement in DNA repair and re-modelling (Mongelard et al., 2007) . PCNA levels are particularly high in proliferating cells and it can prevent cell death by becoming involved in DNA repair (Moldovan et al., 2007; Andersen et al., 2008) . The expression of telomerase may prevent senescence and may have an additional DNA protective effect (Blackburn, 2005) . Collectively, the expression of nucleolin, PCNA and telomerase in the secretory phase endometrium of women with endometriosis may facilitate cell proliferation and support DNA repair/genome stabilization.
Significance of g-H2AX
g-H2AX foci were seen during the proliferative phase in parallel with markers of proliferation, such as PCNA. Secretory phase endometrial cells of fertile healthy women exhibit inhibition of proliferation (Critchley and Healy, 1998) . In the glandular cells, there is the synthesis and release of endometrial secretory products, and apoptosis seen early in the secretory phase in response to the post-ovulatory high progesterone levels (Kokawa et al., 1996; Dahmoun et al., 1999; Rodriguez et al., 2008) . If conception fails to occur, the secretory endometrium undergoes tissue breakdown, apoptosis and menstrual shedding, followed by regeneration on a monthly basis. We have observed an increase in g-H2AX signal (15%) in the stromal cells of late secretory phase endometrium from healthy, fertile women when compared with both the proliferative phase endometrium of fertile women (7.9%) and the late secretory phase endometrium of women with endometriosis (6.7%, P ¼ 0.0001). This might be indicative of induction of cellular senescence in the endometrial stroma during the secretory phase. The presence of g-H2AX foci in the absence of proliferative markers has been proposed as a marker for cellular senescence in vivo (Sedelnikova et al., 2002; Fernandez-Capetillo et al., 2004; von Zglinicki et al., 2004; Fillingham et al., 2006) . In vitro, senescence has been defined as an irreversible loss of replicative capacity of primary human cells (Hayflick and Moorhead, 1961; Hayflick, 1965) . There is some controversy about whether the in vitro phenomenon of senescence is relevant in vivo (Ben-Porath and Weinberg, 2005) . Nevertheless, it has been suggested that cellular senescence is a fundamental cellular programme that is activated in various situations of physiologic stress to prevent further cell proliferation without triggering cell loss, e.g. by apoptosis (Ben-Porath and Weinberg, 2005) . Typically, senescent cells acquire increased adhesion to the extracellular matrix while losing cell -cell contacts and can remain in a viable, non-dividing state for months (Ben-Porath & Weinberg, 2005 and references therein).
Possibly, the g-H2AX signal seen in proliferative phase endometria from healthy women indicates replication stress, while the increase in g-H2AX positivity in the stromal compartment of healthy women in secretory phase suggests induction of cell senescence that may be caused by telomere dysfunction in accordance with the observed decrease in telomerase immune-reactivity (Hapangama et al., 2008a) .
Senescent cells are able to continue with many of their usual functions and have tumour suppressor and anti-proliferative functions. If senescence occurs in the functional layer of the endometrium during the secretory phase, this process may allow many of the terminally differentiated endometrial stromal cells to conserve energy and to be 'focused' on differentiation. It is likely that after the menstrual shedding of the functional layer, the 'so-called' endometrial stem cells (Gargett, 2007) from the basal layer which are not shed will then give rise to the new functional layer and also contribute to the angiogenesis and placentation if pregnancy were to occur.
Samples of endometrium obtained from women with endometriosis yielded different findings. In women with endometriosis, there was a virtual loss of g-H2AX in both glandular and stromal cells despite persistent proliferative markers (ongoing or accelerated proliferation) during the secretory phase. This shows that these cells not only maintain their telomeres (Hapangama et al., 2008a) and do not accumulate DSBs, but also proliferate in the secretory phase without replication fork stalling. With the present data, we cannot discriminate between the possibilities that DNA replication in the secretory phase in women with endometriosis is more efficient (i.e. stalled replication does not occur) or that the ability to recognize a stalled replication fork (i.e. function of Ataxia telangiestasia and Rad3-related kinase (ATR)) is down-regulated. In any case, absence of replication stalling despite significant mitogenic stress could not only contribute to a higher rate of proliferation, and thus to a survival advantage in the peritoneal cavity, but also could decrease the fidelity of DNA replication and thus be a source of potentially dangerous mutation accumulation. This rapid proliferative advantage, with potential high risk of mutation, corresponds with the increasing evidence that endometriosis can sometimes develop into gynaecological cancers (van Gorp et al., 2004) .
Endometrial TL
The correlations seen between mean endometrial TL and the expression of nucleolin, PCNA and telomerase further confirm the biological relevance of TL in the endometrial cells and reinforce our interpretation that eutopic endometrium from women with endometriosis is in a state of sustained replication.
Conclusion
We have immunolocalized nucleolin and g-H2AX in the benign premenopausal endometrium for the first time. The evidence of DNA breaks that we have observed in secretory phase endometrium from healthy, fertile women indicates that the regulation of cell fate in normal endometrium is more complex than has been recognized previously. We have shown the expression of nucleolin, PCNA and telomerase in secretory phase endometrium of women with endometrosis, in the absence of an increase in DNA damage response. These findings demonstrate that the state of replication seen in secretory phase endometrium from women with endometriosis is not a simple extension of the proliferative phase. Taken together, the observations we present here lead us to propose that 'hyper-efficient' proliferation (possibly due to less efficient surveillance of the DNA integrity by ATR and associated kinases, or more competent DNA replication) is an element of the phenotype of endometriosis that could contribute to a survival advantage in the peritoneal cavity. This would allow these cells to implant and give rise to endometriotic deposits. These results require further confirmation in functional studies employing cell culture techniques and the available animal models of endometriosis. Therefore, we have described how endometriosis represents a unique state of excessive proliferation and genome stability without neo-plastic transformation. This underlines the value of endometrial biopsies for in vivo studies of cell fate.
